Advocating for Diversity, Equity, and Inclusion in Dermatology and LGBTQ Health
At the 2021 Skin of Color Update, Dr. Andrew Alexis hosted a panel discussion on Diversity, Equity, and Inclusion (DEI), with dermatology powerhouses Dr. Susan Taylor and Dr. Klint Peebles. These two panelists have tirelessly advocated for their respective causes, advancement of knowledge within skin of color (SOC) and LGBTQ (lesbian, gay, bisexual transgender, queer) health.
Our first panelist …
At the 2021 Skin of Color Update, Dr. Andrew Alexis hosted a panel discussion on Diversity, Equity, and Inclusion (DEI), with dermatology powerhouses Dr. Susan Taylor and Dr. Klint Peebles. These two panelists have tirelessly advocated for their respective causes, advancement of knowledge within skin of color (SOC) and LGBTQ (lesbian, gay, bisexual transgender, queer) health.
Our first panelist … Continue reading "Advocating for Diversity, Equity, and Inclusion in Dermatology and LGBTQ Health"
Hyperhidrosis affects up to 4.8% of people in the United States, causing significant impacts in patient quality of life.1 Often times, the etiology of symptoms cannot be identified, resulting in a subset of disease termed “primary hyperhidrosis.” Symptoms may be focal or generalized. Because there is a scarcity of FDA-approved treatments for primary hyperhidrosis, treatment often requires a mu … 
Dr. Shari Lipner, Associate Professor of Clinical Dermatology and Director of the Nail Division at Weill Cornell Medicine and President of The Dermatologic Society of Greater New York, shared her expertise of nail disorders in patients with skin of color: from nail psoriasis and onychomycosis to subungual melanoma.
Dr. Lipner’s lecture focused on the following key points (spoiler alert!):
… 
Primary hyperhidrosis (PHH) is a dermatologic condition characterized by overactivity of eccrine glands resulting in excessive sweating primarily affecting the palms, soles, axillae, and craniofacial area. PHH is not caused by other conditions, whereas secondary hyperhidrosis is caused by an underlying medical condition or medication side effect. Botulinum toxin injections are often used as second … 
With a special focus on patients with skin of color, the July issue of the Journal of Drugs in Dermatology is packed with outstanding articles, features, and case reports on topics ranging from OTC therapies for hair grow and choosing the right sunscreen in communities of color, to evaluation of a skin of color curriculum for dermatology residents and PLLA for correction of nasolabial folds. Stra … 